Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibition of Polyglutamine Aggregation in R6/2 HD Brain Slices—Complex Dose–Response Profiles

1 Dec 2001

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Neurodegenerative Diseases
Share to Mitochondrial Function and Pathology
Share to Neurological disorders and treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 11741397
DOI: 10.1006/nbdi.2001.0438

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Inhibition of Polyglutamine Aggregation in R6/2 HD Brain Slices—Complex Dose–Response ProfilesPMID 11741397Read ↗

Polyglutamine disorders: Pathogenesis and potential drug interventionsSemantic proximity Read ↗

Polyglutamine Aggregation in Huntington Disease: Does Structure Determine Toxicity?Semantic proximity Read ↗

Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease.Semantic proximity Read ↗

Discovery and Structure–Activity Relationship of Potent and Selective Covalent Inhibitors of Transglutaminase 2 for Huntington’s DiseaseSemantic proximity Read ↗

Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 model.Semantic proximity Read ↗

A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila.Semantic proximity Read ↗

Depletion of Complexin II does not affect disease progression in a mouse model of Huntington's disease (HD); support for role for complexin II in behavioural pathology in a mouse model of HD.Semantic proximity Read ↗

N-phenylamine derivatives as aggregation inhibitors in cell models of tauopathy.Semantic proximity Read ↗

Novel EAAT2 activators improve motor and cognitive impairment in a transgenic model of Huntington’s diseaseSemantic proximity Read ↗

NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.